Impact of bevacizumab added to temozolomide-chemoradiation on time to health-related quality of life deterioration in unresectable glioblastoma: Results of a phase II randomized clinical trial

Affiliation auteurs!!!! Error affiliation !!!!
TitreImpact of bevacizumab added to temozolomide-chemoradiation on time to health-related quality of life deterioration in unresectable glioblastoma: Results of a phase II randomized clinical trial
Type de publicationJournal Article
Year of Publication2015
AuteursBonnetain F, Dabakuyo TSandrine, Pozet A, Feuvret L, Taillandier L, Frappaz D, Taillia H, Schott R, Honnorat J, Fabbro M, Tennevet I, Ghiringhelli F, Campello C, Castera D, Frenay M, Dalban C, Skrzypski J, Chinot OL, Chauffert B, Anota A
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume33
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/jco.2015.33.15_suppl.2018